PT
Autoridade da Concorrência

Case details

Print
Merger control
Case reference
CCENT/2010/36 - Baush & Lomb / Negócio de mióticos injectáveis Novartis Pharma
Acquiring
Bausch & Lomb Incorporated
Description
a company controlled, ultimately, by the investment fund manager Warburg Pincus & Co; it produces, distributes and sells a range of ophthalmic products in 34 countries, including Portugal. B&L offers products in the following segments: eyecare, pharmaceuticals, and cataract and vitreoretinal surgery. The Warburg Pincus Group has interests in investment funds in different business areas such as: financial services, health, the industrial sector, the media, telecommunications, energy and property.
Acquired
Novartis Pharma AG
Description
The business represented in the transaction corresponds to Novartis’ assets relating to the injectable miotic products marketed under the brand name Miochol-E®, namely in Portugal.
Sector
  • Extractive and manufacturing Industries
Activity (NACE)
  • C2120 - Manufacture of pharmaceutical preparations
Applicable legislation
Art. 9(1)(a) (Law 18)
Notification thresholds
Market share
Type of merger
Conglomerate
Cooperation with sector regulators
Status
Closed
Type of Investigation
Phase 1
AdC’s decision
Non-opposition
Case description
Notified on 30 July 2010, this merger operation consists of the acquisition by the undertaking Bausch & Lomb Incorporated ("B&L") of exclusive control of the assets relating to injectable miotics products (“Target Business”) currently owned by Novartis Pharma AG and its associates ("Novartis").
Timeline
2010-09-09
Competition Authority Council adopts a decision of non-opposition to merger operation 36/2010 - Baush & Lomb / Novartis Pharma’s injectable miotics business.
2010-08-19
Publication of the announcement - The undertaking Bausch & Lomb Incorporated ("B&L") notifies acquisition of exclusive control of the assets relating to injectable miotics products (“Target Business”) currently owned by Novartis Pharma AG and its associates ("Novartis").
Click here to see your activities